StockTipsArenaBeta

BUY Cohance Lifesciences Limited — Kunal Saraogi

BUYCohance Lifesciences Limited
Cohance Lifesciences share price target & all analyst calls

byKunal SaraogiHorizon: NA (inferred 1–3 months)18 Aug 2026via Zee Business (Live)

Entry₹459.8Inferred
Target₹530
Total upside +15.27%
Stop loss₹415-9.74% risk
CMP₹449.851d ago
Active-2.16%+17.82%upside left 4 wk left
Follow Kunal Saraogi for new callsGet alertsWatch COHANCE for new buy/sell callsGet alertsSee 39 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 24 Oct, 6:08 pm IST
6 supporting5 neutral4 opposing
Supports the BUY call (6)

3 advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·21 Oct · 3d ago

Neutral / worth noting (5)

Mr. Abhimanyu Ojha has been appointed as the Chief Financial Officer of the company.

BSE · Company Update·9 Oct · 2w ago

(opens in new tab)

Mr. Abhimanyu Ojha has been appointed as the Chief Financial Officer of the company effective October 12, 2026.

NSE · Appointment·9 Oct · 2w ago

(opens in new tab)
Weighs against the BUY call (4)

MACD below its signal line — bearish momentum

Technicals · macd·24 Oct · today

1 advisor has an active long-term SELL call on this stock

Advisor consensus · adjacent horizon·6 Aug · 3mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Cohance Lifesciences

All analyst calls on Cohance Lifesciences

More from Kunal Saraogi

Every call and its outcome